ArticleFrontiers in immunology2026

Case Report: Switching secukinumab to bimekizumab in diffuse cutaneous systemic sclerosis after autologous hematopoietic stem cell transplantation: a case follow-up.

Lea-Kristin Nagler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.